VIAN-c4551 also inhibits the VEGF-induced permeability of endothelial cell monolayers [19] and both VIAN-c4551 [19] and vasoinhibin [40,42] protect against disruption of the blood retinal barrier in experimental models of diabetic retinopathy. This evidence concerns the gene VEGFA and diabetic retinopathy.